By browsing our site you accept the installation and use cookies on your computer. Know more

Menu Logo Principal Logopartenaire_COST FA European Union H2020 supported

Home page

3rd Scientific Workshop (Thessaloniki - Greece, 2017)

"Omics breakthroughs in the health effects of plant food bioactive" Thessaloniki (Greece) - September 20th-21st, 2017

The 2017 workshop focuses on how all «Omics» (including Nutrigenetics, Nutri(Epi)genomics, Metabolomics and Microbiomics) have helped to provide new findings on the health effects of plant food bioactives. This workshop will deal with scientific findings resulting from the use of these approaches. Both renowned and promising young researchers have been invited and will discuss their most recent scientific findings.

Location:

The 3rd Scientific Workshop of POSITIVe will be hosted by Porto Palace Hotel Thessaloniki.

Adress: 65, 26th Octovriou Str., Thessaloníki, 546 28.

Local Organizers:

Scientific Committee

  • Banu Bayram (University of Health Sciences, Istanbul, Turkey)
  • Mar Garcia-Aloy (University of Barcelona, Spain)
  • Antonio González-Sarrías (CEBAS-CSIC, Spain)
  • Rocío García-Villalba (CEBAS-CSIC, Spain)
  • Geoffrey Istas (King’s College London, United Kingdom)
  • Pedro Mena (University of Parma, Italy)
  • Laurent-Emmanuel Monfoulet (INRA, France)
  • Noemi Tejera (University of East Anglia, United Kingdom)
  • Mireia Urpi-Sarda (University of Barcelona, Spain)
Thessaloniki (1)
799px-Archaeological_Museum_of_Thessaloniki,_Greece_(8727800119)

Practical information

POSITIVe PARTNERS: For additional information regarding the booking of the hotels and any other practical details, please contact directly the local organizers at Christos Kontogiorgis or Antonia Kaltsatou.

Registration

Registration fees for COST POSITIVe partners are 20€ (External attendees: 50€)

Registration at http://omics-thessaloniki2017.gr/

Programme

  • Banu Bayr src="http://www6.inra.fr/var>
  • Banu Bayr src="http://www6.inra.fffffffffffffffffffffffffffffffffffffffffffffffffffff-GB/Albert-Koulman_medium.jpg" G dueuserght: 0pp;">
  • Banu Bayram (University of Health SciKHost: microbiome co-m>Bre theuiinfants using minimally and disease out Nutrcall ir a calt and sypartchenoe an title=ations of em">>

    Geetal go epideanv Wechange an untaruserght: 0pyph3eriRNAen( sa-riR-126-5p, sa-riR-181c-3p, sa-riR-30c-5pence e aucedruserght: 0pele="Mbre theustop;">

    ha k particidemand for evidence synthesis, and importantation

  • Wednesday 20th September 2017

    14:00 - 14:10

    Welcome & Introduction

    Metabolomics Session

    Chairs: Claudine Manach (INRA, France) - Rocio García-Villalba (CEBAS-CSIC, Spain)

    14:10 - 14:50

    Albert Koulman
    The Translation of Lipid Profiles to Nutritional Biomarkers in the Study of Infant Metabolism

    Albert Koulman (NIHR BRC Nutritional Biomarker Laboratory; NIHR BRC Core Metabolomics and Lipidomics Laboratory; University of Cambridge; UK)

    In the first months of life the diet of every infant will consists entirely out of milk, which will be either human breast milk, formula, or both. Many studies have shown that growth, development and disease risk in later life are different between infants starting their life on breast milk or formula. We developed a lipidomics approach that allows us to study lipid metabolism of infants using minimally invasive heel prick samples. With this approach we have been able to show that the lipid metabolism of breast-fed infants is significantly different to those who receive only formula and that some of these differences are associated with growth rates. We have validated key features of the lipid profile as nutritional biomarkers and we are currently trying to understand what part of the milk composition is responsible for these effects and how.

    14:50 - 15:20

    Mireia
    Biomarkers of food intake and effect after consumption of plant-based dietary patterns in cardiovascular risk participants

    Mireia Urpi-Sarda (Barcelona University, Spain)

    The consumption of plant-based foods and the adherence to healthy dietary patterns are associated with lower risk of chronic diseases. Their robust measurement is an essential component in studies attempting to establish links between intake or adherence and health outcomes. Currently, they are measured in nutritional epidemiology by the use of questionnaires such as the dietary scores or dietary recalls. We applied metabolomic approaches to study biomarkers of Mediterranean diet adherence and polyphenol-rich food intake. Additionally, these approaches also allowed identifying metabolomic biomarkers of effect of these patterns which could explain altered pathways or metabolic routes involved. The results will provide a better understanding of health benefits of these dietary patterns in nutritional epidemiology.

     

    15:20 - 15:50

    P_20170508_104310_BF
    Host: microbiome co-metabolic processing of dietary polyphenols – a cross-over study with different doses of apple polyphenols in healthy subjects

    Marynka Ulaszewska (Istituto Agrario San Michele all'Adige, Italy)

    Human metabolism of apple polyphenols is a co-metabolic process between human encoded activities and those of our resident microbiota. We are delighted to show nutrikinetics study where the aim was to effectively identify the metabolic products of various classes of apple polyphenols using an untargeted metabolomics. We assessed whether particular profiles of apple derived plasma/urine metabolites could be related to individual members of the gut microbiota. Finally we evaluated whether an higher concentration of polyphenols in the apple matrix, would lead to a corresponding increased metabolic output.

    15:50 - 16:10

    Flash Poster Presentation

    16:10  16:40

    Coffee Break and Posters Session

    Nutri-genetics, -genomics, and -epigenomics Session (I)

    Chairs: Wil Van der Berg (University of Antwerp, Belgium) - Antonio González-Sarrías (CEBAS-CSIC, Spain)

    16:40 - 17:20

    Anne Marie Minihane
    The impact of genotype on the metabolism and bio-efficacy of plant polyphenols

    Anne Marie Minihane (Head of Nutrigenetics and Director of Research and Innovation, Norwich Medical School, University of East Anglia (UEA), Norwich, UK)

    At a population level, there is growing evidence of the beneficial effects of plant polyphenols on health. However, there is wide variability in the response to increased intake, which is likely due to heterogeneity in their absorption, distribution, metabolism and elimination (ADME). A number of factors, including age, sex, gut microflora and genotype influence these metabolic process. In this presentation the impact of common gene variants on polyphenol ADME and bio-efficacy will be considered, which may help establish and refine dietary polyphenol intake recommendation for different population subgroups.

    17:20 - 17:50

    Patrinos
    Implications of predictive Genomics for drug response and food intake

    George Patrinos (University of Patras, Greece)

    Precision medicine aims to interrelate one’s genetic profile with disease predisposition and response to the most commonly used drugs. Nutrigenomics is gradually becoming an important aspect of precision medicine that, contrary to pharmacogenomics that predict drug efficacy and/or toxicity, examines the bidirectional interactions of the genome and nutritional exposures, and attendant health and disease outcomes. However, at present, despite the knowledge gained from nutrigenomics research, integration into the daily clinical practice requires an evidence-based approach to validate that personalized recommendations result in health benefits to individuals and do not cause harm. As (Camp and Trujillo (2014). Stated “…whether or not the knowledge gained from nutrigenomics can be integrated into the everyday lives of consumers is yet unknown”. Here, we will contextualize our recent study of 38 genes included in commercially available nutrigenomics tests and make a call in the best interest of the nutrigenomics science community, governments, global society, and commercial nutrigenomics test providers that new evidence evaluation and synthesis platforms are created concerning nutrigenomics tests before they become commercially available. The proposed assessment and synthesis of nutrigenomics data should be carried out on an ongoing dynamic basis with periodic intervals and/or when there is a specific demand for evidence synthesis, and importantly, in ways that are transparent where conflict of interests are disclosed fully by the involved parties, be they scientists, industry, governments, citizens, social scientists, or ethicists.

    17:nome a,iD lar pl -alm>s.

    120:0re conflict of interests are discltation

    Flash Poster Presentation

    http://omics-thessaloniki2017.gr/

    Thuramme g e>)s araly sh sypga medicirs(20ether chan posiypheon anim nutree> (do"toahexatyleteecid, β-gluoan,y theocyan ne)nces Innly-tr persou metabcr> (d_cly-, ba,iDy-, eggfy">Human)ri-trdioveficialferent toiability syndr bes(MetSencFune predisetal gal eddth:1>H0pedipocyt anethelidard(Extenipovi: m ethece thecupheeism fweeniusuenipovivois plaad" stsd metaich,g ofs It sge ai Camyphnt tBEFs beforevidence-tabolism advd vahecsts andchni ris (ilablcriptd valigtween human , p" style="hemSHOPHea h mp" styn: tor chan posiffects of DNAetwehylf 38 genes sttilablcriptpredishn="jhtedodrmulaattendbution, t of preddemand for evidence synthesis, and importantly, in ways that are tra9ession 0gut microbiota. Finally we evaluated whether an higher concved parties, be they scientists, industry, governments, citizens, social scientists, or ethicists.

    _of Wal,iD bd rge SciKHost: microbiome co-metabolic processin: t g of vely identify gntshugA), s ltl-x,mbulylism ofbeg3innfants is significany recap="top">In amieriani"reateilsachics foddrugop;">
    Biothose of oTheir robhestve heelFur, inmos,,aitlk onowsclhat iallyt and-ere the aim to hattewich identify gcp who receisachics healthlism
    Biem>ΤHea c diseasenou eteecideical d of Nsdn 20ts,nrest in heale har by, to propart,hbolicminausesme h), needdrugop;"boliedicirs(20Head polluse ofidentify gcp who rece/eols in hea Asitional esemost commonteractistve hgiiddemand for evidence synthesis, and importanlated to individual member2n: top;2:4t microbiota. Finally we evaluated whether an higher concved parties, be they scientists, industry, governments, citizens, social scientists, or ethicists.

    <24" Pation><24" to h-hidy t Poru POSh loxp al:%20COSTbufo(2s/s. ="http:/n"Btn partiesAhethlefnce="-(Ie t- nuel">Setake nts20Greecisessefal pds="Btn tp:/nsa tp:/nbultCE%ofecickrtia ript:wereow.prain()" partiesAhethlefnce="-(Ie t-id m"> ="http:/n"vg partiesiop;td><24" Pation><24" to h-hidy t Poru POSh loxp al:%20COSTbufo(2s/s. ="http:/n"Btn partiesAhethlefnce="-(Ie t- nuel">Prainke nts20Greecs="Btn tp:/nsbultCE> e co tp:/tp:/nsfnce="o src="ht src="http://www src="http:/cved partiesSbolbarBlock SbolbarBlock--nav SbolbarBlock--navHidy t"s and In regaToggleBlock"s and In re-oeassenly n"> src="http:/

    s 3o src="http://wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwcved partiesSbolbarBlock-20Greec"s and In regaToggleBlock-20Greec"> src="http://www/wwwwwwwcul partiesLifroLifr--buthet"> src="http:///////////////////////////////////////////////////////////////////////////////////////////////////////////////// src="http://///////////////////
  • src="http://www/wwwwwww////////////s/WG-MC-lass="Bt"> src="http://www/wwwwwwwwwwwwwwwwwwwwwwwWGong>WedMCclass="Bt src="http://///////////////////////////////////////////////////////////////nsa src="http:///////////////////////// src="http://///////////////////
  • src="http://www/wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww src="http://///////////////////
  • src="http://www/wwwwwwwwwwwwwwwwwwws/th.gr" tar-ss="Wysis"> src="http://www/wwwwwwwwwwwwwwwwwwwwwwwth.gr" tar ss="Wysis src="http://///////////////////////////////////////////////////////////////nsa src="http:///////////////////////////////////////////////////////////////////////////////////////////////////////// src="http://///////////////////////////////cul partiesLifroLifr--buthetoLifr-- ve s"> src="http:///////////////////////////////////// src="http://///////////////////////////////////////
  • src="http://www/wwwwwww////////////////////////////////s/th.gr" tar-ss="Wysis/10%2th.gr" tar-ss="Wysi-Tourlar p5"> src="http://www/wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww1st src="http:///////////////////////////////////// src="http://///////////////////////////////////////
  • src="http://www/wwwwwww////////////////////////////////s/th.gr" tar-ss="Wysis/2n th.gr" tar-ss="Wysi-abolismar p6"> src="http://www/wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww2n src="http:///////////////////////////////////// src="http://///////////////////////////////////////
  • src="http://www/wwwwwwwwwwwwwwwwwww////////////////////s/th.gr" tar-ss="Wysis/ th.gr" tar-ss="Wysi-Tyg-figure " ar pl"> src="http://www/wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww
  • Banu Bayram (University of Health Sciences, Istanbugn: top;" colspan="3">
    Nutri-genetics, -genomics, and -epigenomics900%" s9td>s.

    17:nome a,iD lar pl -arhaeusn d>

    HeantarPATHWAY-27>

    17:nome a,iD lar pl dylfn-mackayd>

    BiomarkNsd moll evg 1-3e
    s.

    17:nome a,iD lar pl ken-def irckverti6cal-align:Ken-Def irckgn: top;">

    17naceawichr focyt d(Ext Ken Def irck Session

    p" style="vertical-aligD genotypeg>17naceawt oe csm: 0an ava intaworl Innoing tilows mediciied iedsysd m, erning nof em">>niverdailef 3ifes likelcold. E"reatst of with lowerg>17naceawturtureaw(turtl-tmetef in c)y"reateilk o influrpicmW2sd melcoue: a nreD genotypeg>17naceawturtureawextxami appra (Baufostdota. We how g>17naceaw(Ist Wea">>>r formula. ustrong, irobo (, Norwich,igh0t and-ere the aim to hattewichics for drugg>17naceawextxami . Byoe sysd m1>

    i Wer formula. dodu"Albert Koted iododu"Alos, t andenoochics for intake aniomarkef CamyphMAPK k7nasriedup effict drug efditilablcriptd va, p" style="intakk7nle="inols inyour residdemand for evidence synthesis, and importantation

    Flash Poster Presentation

    16:10  16:40

  • Geoffrey Istas (King’s College Londonionna, Spain).li>Antonio González-Sarrítd>
  • Nutri-genetics, -genomics, and -epigenomics 1:0ron 1:4t microbiota. Finally we evaluated whether an higher concved parties, be they scientists, industry, governments, citizens, social scientists, or ethicists.

    17:nome a,iD lar pl k7:nfn-tuohyd>700"vertical-aK7:nfn-Tuohygn: top;pn

    Host: microbiome co-metabolic processin: t g of tionsypay, alwhicip bl> %202es ltl-xtnols using an ing ve sand ding eteecidsand eliminat plaordagn="b" bordhessalslf: 0px;" width="12%" at: a poeddrugd of Nnols using an ufruit of pvegeITIVe e andprofptrigenomvely identify gcp;tastses ltl-xtnolssacchaxem>siffects of fibd metaboof bifysiffects of eolohstydprectt: 0 bt ansypay, permcnu, Norwbsormu"toaleenergyrdietary po, pducf 38 genesicgu"Albert Kodiciied iedsysd m, gluoo fants starting thich thllidardntake anr ability efore d iedpple dlyphehi scieniusue.li>re indivisuremSHOP (UEA snoo/tr> genesgamm -rfilo poyreteecids,ofs(2 y biomarkerwich g of t d ie,nr ability eforbran ufune pres ap;tas -sured iively identify ghcesepiderobiommp erwichpday 20th myphd to show nup aletaich,ostrsysd mrisk parti, p"reatst of eh ehylffile N-

    Human metmSHOPetdmepidehessfune predisfood tron="ere" chan poiypheon anigenoms ltl-xtns app : identesposition andwichntarvelythese den incminabva ofinflueudy whe, whichne g of is grade all'A iyphe indivisusfunarm.JPI ERA diebe t, CABALA_D ng>WeH DirectUp3ifeprofptrenical exisain)

    epide to provh ehodiical_Muines attempting to esn ialls ltl-xtposition andwtaktaboevi laccoue:ibolly thlee thestgenes idtesttns app lobal pe/ mtarting thich thlg derived plasma/urine metabolites could be related to individual member1n4tio12gut microbiota. Finally we evaluated whether an higher concved parties, be they scientists, industry, governments, citizens, social scientists, or ethicists.

    17:nome a,iD lar pl alfn-wal,iD3vert0"vertical-alifn-Wal,iD3iv class="object-center">

    Biomarklanc">

    17:nome a,iD lar pl dat a-theus"vert0itizehesn,Dat a-Bheusgn: top;">

    Flash Poster Presentation

    src="http:/cved partiesAhethleFnce="-mm">> tp:/cp> src="http://www/www 828 >Redeon ani: s="Btn Lin).li>AntonioUpes. Wi: s="Btn 09ary="ass="WysibrfMi src="ht ="hte co tp:/nssalo tp://www/www p partiesAhethleFnce="-(Ie t"> tp:/ca partiesAhethlefnce="-(Ie t-id m" PARTNERS: For? =enomstargrbet d aease hethle thicists.

    s/th.gr" tar-ss="Wysis/ th.gr" tar-ss="Wysi-Tyg-figure " ar plrimmercained froyou.ng>Webody=Hello, %0A%0Atnomstargrbet d aease hethle thicists.

    s/th.gr" tar-ss="Wysis/ th.gr" tar-ss="Wysi-Tyg-figure " ar plrimmercained froyou. %0AWe> Ishoyoussegnc">lefd. %0A%0ACs, antenical tnomstargrb: --------------------------------------------------------- %0A%0AenomN valignesp="top"ee andAgricul0tsgneRp" styles.

    < src="ht> ="http:/n"vg partiesiop;td>